Fused indane compound
To provide a compound which is useful as an NMDA receptor antagonist. The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Hayashibe, Satoshi Yamasaki, Shingo Shiraishi, Nobuyuki Hoshii, Hiroaki Tobe, Takahiko |
| description | To provide a compound which is useful as an NMDA receptor antagonist. The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08211907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08211907</sourcerecordid><originalsourceid>FETCH-uspatents_grants_082119073</originalsourceid><addsrcrecordid>eNrjZBB1Ky1OTVHIzEtJzEtVSM7PLcgvzUvhYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDCyNDQ0sDcmAglAFXmIe0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fused indane compound</title><source>USPTO Issued Patents</source><creator>Hayashibe, Satoshi ; Yamasaki, Shingo ; Shiraishi, Nobuyuki ; Hoshii, Hiroaki ; Tobe, Takahiko</creator><creatorcontrib>Hayashibe, Satoshi ; Yamasaki, Shingo ; Shiraishi, Nobuyuki ; Hoshii, Hiroaki ; Tobe, Takahiko ; Astellas Pharma Inc</creatorcontrib><description>To provide a compound which is useful as an NMDA receptor antagonist. The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8211907$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,309,781,803,886,64043</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8211907$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hayashibe, Satoshi</creatorcontrib><creatorcontrib>Yamasaki, Shingo</creatorcontrib><creatorcontrib>Shiraishi, Nobuyuki</creatorcontrib><creatorcontrib>Hoshii, Hiroaki</creatorcontrib><creatorcontrib>Tobe, Takahiko</creatorcontrib><creatorcontrib>Astellas Pharma Inc</creatorcontrib><title>Fused indane compound</title><description>To provide a compound which is useful as an NMDA receptor antagonist. The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZBB1Ky1OTVHIzEtJzEtVSM7PLcgvzUvhYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDCyNDQ0sDcmAglAFXmIe0</recordid><startdate>20120703</startdate><enddate>20120703</enddate><creator>Hayashibe, Satoshi</creator><creator>Yamasaki, Shingo</creator><creator>Shiraishi, Nobuyuki</creator><creator>Hoshii, Hiroaki</creator><creator>Tobe, Takahiko</creator><scope>EFH</scope></search><sort><creationdate>20120703</creationdate><title>Fused indane compound</title><author>Hayashibe, Satoshi ; Yamasaki, Shingo ; Shiraishi, Nobuyuki ; Hoshii, Hiroaki ; Tobe, Takahiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_082119073</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Hayashibe, Satoshi</creatorcontrib><creatorcontrib>Yamasaki, Shingo</creatorcontrib><creatorcontrib>Shiraishi, Nobuyuki</creatorcontrib><creatorcontrib>Hoshii, Hiroaki</creatorcontrib><creatorcontrib>Tobe, Takahiko</creatorcontrib><creatorcontrib>Astellas Pharma Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hayashibe, Satoshi</au><au>Yamasaki, Shingo</au><au>Shiraishi, Nobuyuki</au><au>Hoshii, Hiroaki</au><au>Tobe, Takahiko</au><aucorp>Astellas Pharma Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fused indane compound</title><date>2012-07-03</date><risdate>2012</risdate><abstract>To provide a compound which is useful as an NMDA receptor antagonist. The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_08211907 |
| source | USPTO Issued Patents |
| title | Fused indane compound |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T07%3A08%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hayashibe,%20Satoshi&rft.aucorp=Astellas%20Pharma%20Inc&rft.date=2012-07-03&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08211907%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |